Karachi: Dow University of Health Sciences (DUHS) on Monday announced that its medical experts had made significant headway in the treatment of COVID-19 using blood plasma from recovered patients, a news source reported.
As per the publication, the experts claimed that Intravenous Immunoglobulin (IVIG) could treat coronavirus patients. Professor Muhammad Saeed Qureshi stated that IVIG was an amazing development in the fight against COVID-19. He further revealed that the globulin was recovered from the blood of infected patients and purified — after which the experts remove unnecessary materials through ultra-purification techniques.
The experts claimed that the method employed to manufacture the globulin was approved by the United States Food and Drug Administration (FDA). Through their experiments, the university’s researchers now believe that the aforementioned treatment could be quite effective. The DUHS experts also argued that the strain of COVID-19 in Pakistan had undergone a few mutations and that the IVIG extracted from recovered patients in the country would provide immunity against the virus.
